Home
Corporate Governance
Stock Information
Stock QuoteAnalyst Coverage
Information Disclosure
Listing DocumentsAnnouncements & CircularsNews
Quarterly Results
Investor Contact
Email SubscriptionContact Information
简繁EN
LongBio
Home
Corporate Governance
Stock QuoteAnalyst Coverage
Listing DocumentsAnnouncements & CircularsNews
Quarterly Results
Email SubscriptionContact Information
简繁EN

Welcome to Email Subscription

Dear investors, thank you for your support and attention! We are committed to establishing an open and transparent communication mechanism and sincerely invite you to actively participate in investor consultation.
Below this section, you can leave your valuable suggestions. We will carefully listen to the feedback from every investor and regularly provide written feedback to the company management, with targeted responses in periodic reports.
The voice of investors is the driving force for our progress. Your participation will inject new vitality into the company's development. We look forward to your participation in jointly promoting the company's development and creating a better future together.

Name
Email
Verification Code
Send code
ABOUT
companyhistoryteam
PLATFORM
High-Affinity Antibody
Discovery Platform
Bi-Functional Antibody
Development Platform
SCIENCE
PipelineLP-003LP-005
NEWS
Lastest News
CONTACT

5th Floor, Building F, Area A, No. 128 Yinhe Road, Dongnan Subdistrict, Changshu City, Suzhou City, Jiangsu Province, PRC

bd@longbio.com; ir@longbiopharma.com

021-58372970

© LongBio, 2025, All rights reserved. 苏ICP备2022007119号-3